Ponstel
Ponstel (mefenamic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and menstrual discomfort. It works by blocking the production of prostaglandins, which are chemicals that cause pain, fever, and inflammation in the body.
Dosage by Body Weight
For patients 14 years and older, the recommended dose is 500 mg as an initial dose, followed by 250 mg every 6 hours as needed, usually not to exceed one week. Take with food or milk to minimize gastrointestinal upset.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and effectiveness in pediatric patients under 14 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Contraindicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and effectiveness in pediatric patients under 14 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Contraindicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and effectiveness in pediatric patients under 14 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Contraindicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and effectiveness in pediatric patients under 14 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Contraindicated
- Frequency
- Not applicable
- Tracking Notes
- Safety and effectiveness in pediatric patients under 14 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated | Not applicable | Safety and effectiveness in pediatric patients under 14 years of age have not been established. |
| 5-7 kg | Contraindicated | Not applicable | Safety and effectiveness in pediatric patients under 14 years of age have not been established. |
| 8-10 kg | Contraindicated | Not applicable | Safety and effectiveness in pediatric patients under 14 years of age have not been established. |
| 11-15 kg | Contraindicated | Not applicable | Safety and effectiveness in pediatric patients under 14 years of age have not been established. |
| 16-20 kg | Contraindicated | Not applicable | Safety and effectiveness in pediatric patients under 14 years of age have not been established. |
Formulation
Purpose
Short-term treatment (up to 7 days) of mild to moderate pain, and treatment of primary dysmenorrhea (menstrual cramps).
Generic Name
Mefenamic acidScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.